TITLE

The TCR/CD3 Complex: Opening the Gate to Successful Vaccination

AUTHOR(S)
Portolés, Pilar; Rojo, Jose M.
PUB. DATE
October 2009
SOURCE
Current Pharmaceutical Design;10/1/2009, Vol. 15 Issue 28, p3290
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The success of vaccination is directly or indirectly based on the specificity of antigen recognition by T lymphocytes, their efficient activation and expansion, and the generation of vaccine-specific effector and memory cells. These traits are largely dependent on the correct assembly and expression of sufficient number of functional TCR/CD3 complexes in the cell surface. In this review, some of the genetic and epigenetic factors that determine the correct assembly and structure of the TCR/CD3 complex are summarized. Those physiologic or pathologic factors leading to natural variations, or pathologic alterations of the standard that might lead to poor response to vaccination and that could give some possibilities to pharmacological intervention are emphasized.
ACCESSION #
43974809

 

Related Articles

  • Prospects and Limitations of T Cell Receptor Gene Therapy. Jorritsma, Annelies; Schotte, Remko; Coccoris, Miriam; de Witte, Moniek A.; Schumacher, Ton N. M. // Current Gene Therapy;Aug2011, Vol. 11 Issue 4, p276 

    No abstract available.

  • Antigen-recognition properties of murine ϒδ T cells. Chien, Y.-H.; Hampl, J. // Springer Seminars in Immunopathology;2000, Vol. 22 Issue 3, p239 

    Explores the antigen-recognition properties of murine gamma/delta T cells. Structural differences between murine T10/T22 ligands of peripheral gamma/delta T cells and classical major histocompatibility complex class I molecules; Possible contact sites of the G8 T cell receptor with T10;...

  • Production of LacZ Inducible T Cell Hybridoma Specific for Human and Mouse gp10025–33 Peptides. Cafri, Gal; Sharbi-Yunger, Adi; Tzehoval, Esther; Eisenbach, Lea // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Identification and quantification of immunogenic peptides and tumor-derived epitopes presented on MHC-I molecules are essential for basic studies and vaccines generation. Although lymphocytes derived from transgenic mice can serve as sensitive detectors of processes of antigen presentation and...

  • Taking the easy way out? Schuldt, Alison // Nature Cell Biology;Sep2002, Vol. 4 Issue 9, pE213 

    Examines how the major histocompatibility complex class-II (MHC-II) molecules escape the lysosomes and move to the cell surface. Role of MHC-II in dendritic cell maturation; Use of the internal reflection microscopy to test whether tubules actually mediate transport to the cell surface.

  • HLA class I supertypes: a revised and updated classification. Sidney, John; Peters, Bjoern; Frahm, Nicole; Brander, Christian; Sette, Alessandro // BMC Immunology;2008, Vol. 9, Special section p1 

    Background: Class I major histocompatibility complex (MHC) molecules bind, and present to T cells, short peptides derived from intracellular processing of proteins. The peptide repertoire of a specific molecule is to a large extent determined by the molecular structure accommodating so-called...

  • Prime-Boost Vaccination with rBCG/rAd35 Enhances CD8+ Cytolytic T-Cell Responses in Lesions from Mycobacterium Tuberculosis - Infected Primates. Rahman, Sayma; Magalhaes, Isabelle; Rahman, Jubayer; Ahmed, Raija K.; Sizemore, Donata R.; Scanga, Charles A.; Weichold, Frank; Verreck, Frank; Kondova, Ivanela; Sadoff, Jerry; Thorstensson, Rigmor; Spångberg, Mats; Svensson, Mattias; Andersson, Jan; Maeurer, Markus; Brighenti, Susanna // Molecular Medicine;Apr2012, Vol. 18 Issue 4, p647 

    To prevent the global spread of tuberculosis (TB) infection, a novel vaccine that triggers potent and long-lived immunity is urgently required. A plasmid-based vaccine has been developed to enhance activation of major histocompatibility complex (MHC) class I-restricted CD8+ cytolytic T cells...

  • MHC class II molecules on the move for successful antigen presentation. Rocha, Nuno; Neefjes, Jacques // EMBO Journal;1/9/2008, Vol. 27 Issue 1, p1 

    Major histocompatibility complex class II (MHC II) molecules are targeted to endocytic compartments, known as MIIC, by the invariant chain (Ii) that is degraded upon arrival in these compartments. MHC II acquire antigenic fragments from endocytosed proteins for presentation at the cell surface....

  • Signaling negative selection: is MINK the missing link? Palmer, Ed // Nature Immunology;Jan2005, Vol. 6 Issue 1, p9 

    The article presents news related to developments in the immunology field. The signaling pathways that differentiate the positive and negative thymic selection are critical for establishing T cell immunity and tolerance. The kinase MINK might be an important component that differentiates these...

  • Target HCV NS3 CD4+ Th1 Epitope to Major Histocompatibility Complex Class II Pathway. Ming Gao; Hai-Ping Wang; Yan-Ning Wang; Yong Zhou; Quan-Li Wang // Biotechnology Letters;Jan2006, Vol. 28 Issue 1, p3 

    A hepatitis C virus (HCV) plasmid vaccine was constructed, based on class II-associated invariant chain peptide (CLIP) substitution which endogenously targets HCV non-structure protein 3 (NS3) CD4+ T helper 1(Th1) epitope (1248AA-1261AA) to major histocompatibility complex (MHC) class II...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics